Senior Research Investigator II, Leads Discovery & Optimization, Bristol Myers Squibb, Princeton, NJ, USA
BIOGRAPHY
Dr. Koenitzer will present an overview of her current research in immune suppression. After a brief introduction to the MILLIPLEX® multiplex immunoassay portfolio, Dr. Koenitzer will discuss profiling biomarkers relevent to the immuno-oncology space, including checkpoint inhibitors, cytokines, and cancer biomarkers, using MILLIPLEX® multiplex immunoassays.
Learning Objectives:
1. Successfully integrating MILLIPLEX® multiplex immunoassays into your workflow
2. Generating high quality discovery data using multiplex protein detection assays
3. How monitoring cytokines and checkpoint proteins contribute to better sample profiling